Scilex Holding SCLX
NASDAQ SCLX
$5.73 -0.07 (-1.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Other Non Operating Income (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Other Non Operating Income of $25.7 million for Q1 2026, up 147.2% year-over-year from $10.4 million in Q1 2025, and up 36.53% quarter-over-quarter from $18.8 million in Q4 2025.

Scilex Holding (SCLX) Other Non Operating Income (2021 - 2026) Analysis & Trends

Scilex Holding's Other Non Operating Income history runs 6 years deep, the most recent figure standing at $25.7 million for Q1 2026.

  • In Q1 2026, Other Non Operating Income rose 147.2% year-over-year to $25.7 million; the TTM figure through Mar 2026 stood at -$26.2 million (down 188.3% YoY), while the FY2025 annual figure was $21.8 million, up 25.29% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $25.7 million, up from $18.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $33.4 million in Q3 2022, with the low at -$58.4 million in Q3 2025.
  • The 5-year median for Other Non Operating Income is $2.4 million (2022), against an average of $3.1 million.
  • The sharpest annual moves came in 2022 and 2025: Other Non Operating Income soared 2775.21% in 2022, then slumped 126763.04% in 2025.
  • Scilex Holding's Other Non Operating Income stood at $2.4 million in 2022, then jumped by 98.48% to $4.8 million in 2023, then soared by 261.95% to $17.5 million in 2024, then gained by 7.87% to $18.8 million in 2025, then jumped by 36.53% to $25.7 million in 2026.
  • Business Quant data shows SCLX's Other Non Operating Income at $25.7 million in Q1 2026, $18.8 million in Q4 2025, and -$58.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Scilex Holding 39.22 Mn -73.57 Mn 3.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 25.71 Mn
Dec 31, 2025 18.83 Mn
Sep 30, 2025 -58.36 Mn
Jun 30, 2025 -12.38 Mn
Mar 31, 2025 10.40 Mn
Dec 31, 2024 17.46 Mn
Sep 30, 2024 -46,000.00
Jun 30, 2024 1.85 Mn
Mar 31, 2024 -457,000.00
Dec 31, 2023 4.82 Mn
Jun 30, 2023 -82,000.00
Mar 31, 2023 -5.25 Mn
Dec 31, 2022 2.43 Mn
Sep 30, 2022 33.43 Mn
Mar 31, 2022 7.50 Mn
Dec 31, 2021 2.82 Mn
Sep 30, 2021 1.16 Mn
Jun 30, 2021 68,400.00
Mar 31, 2021 -2.60 Mn